The genetics of hydatidiform moles: new lights on an ancient disease

被引:51
作者
Slim, R.
Mehio, A.
机构
[1] McGill Univ, Ctr Hlth, Dept Human Genet, Montreal, PQ H3G 1A4, Canada
[2] McGill Univ, Ctr Hlth, Dept Obstet & Gynecol, Montreal, PQ H3G 1A4, Canada
[3] McGill Univ, Ctr Hlth, Dept Pathol, Montreal, PQ H3G 1A4, Canada
关键词
hydatidiform moles; spontaneous abortions; NALP7; inflammation; molar pregnancies; recurrent hydatidiform moles; familial hydatidiform moles; GESTATIONAL TROPHOBLASTIC DISEASE; RECURRENT MOLAR PREGNANCIES; LYMPHOCYTE-TRANSFORMATION; ANDROGENETIC ORIGIN; LEUKOCYTE-CULTURES; IMPLANTATION SITE; BLIGHTED OVA; EPIDEMIOLOGY; PROTEIN; KARYOTYPE;
D O I
10.1111/j.1399-0004.2006.00697.x
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Hydatidiform mole (HM) is a human pregnancy with no embryo but cystic degeneration of chorionic villi. The common form of this condition occurs in 1 in every 1500 pregnancies in western societies and at a higher incidence in some geographic regions and populations. Recurrent moles account for 2% of all molar cases and a few of them occur in more than one family member. By studying a familial form of recurrent moles, a recessive maternal locus responsible for this condition was mapped to 19q13.4 and causative mutations identified. The defective protein, NALP7, is part of the CATERPILLAR protein family with roles in pathogen-induced inflammation and apoptosis. The exact role of NALP7 in the pathophysiology of molar pregnancies is unknown yet. NALP7 could have a role either in oogenesis or in the endometrium during trophoblast invasion and decidualization. In this review, we outlined recent advances in the field of HMs and reviewed the literature in the light of the new data.
引用
收藏
页码:25 / 34
页数:10
相关论文
共 90 条
[11]   INCIDENCE AND ETIOLOGY OF HYDATIDIFORM MOLE - AN EPIDEMIOLOGICAL REVIEW [J].
BRACKEN, MB .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1987, 94 (12) :1123-1135
[12]  
Brews A., 1939, J OBSTET GYN BR EMP, V46, P813, DOI DOI 10.1111/J.1471-0528.1939.TB07558.X
[13]   CTCF, a candidate trans-acting factor for X-inactivation choice [J].
Chao, W ;
Huynh, KD ;
Spencer, RJ ;
Davidow, LS ;
Lee, JT .
SCIENCE, 2002, 295 (5553) :345-347
[14]   Cytokines, implantation and early abortion:: re-examining the Th1/Th2 paradigm leads to question the single pathway, single therapy concept [J].
Chaouat, G ;
Lédéé-Bataille, N ;
Zourbas, S ;
Ostojic, S ;
Dubanchet, S ;
Martal, J ;
Frydman, R .
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2003, 50 (03) :177-186
[15]  
Copeland LJ, 1993, TXB GYNECOLOGY, P1133
[16]  
COUILLIN P, 1985, HUM GENET, V71, P113
[17]  
Coullin P, 2005, Gynecol Obstet Fertil, V33, P469, DOI 10.1016/j.gyobfe.2005.05.023
[18]  
CRAIGHILL MC, 1984, J REPROD MED, V29, P784
[19]   Bovine mater-like NALP9 is an oocyte marker gene [J].
Dalbiès-Tran, R ;
Papillier, P ;
Pennetier, S ;
Uzbekova, S ;
Monget, P .
MOLECULAR REPRODUCTION AND DEVELOPMENT, 2005, 71 (04) :414-421
[20]   Familial molar tissues due to mutations in the inflammatory gene, NALP7, have normal postzygotic DNA methylation [J].
Djuric, Ugljesa ;
El-Maarri, Osman ;
Lamb, Barbara ;
Kuick, Rork ;
Seoud, Muheiddine ;
Coullin, Philippe ;
Oldenburg, Johannes ;
Hanash, Samir ;
Slim, Rima .
HUMAN GENETICS, 2006, 120 (03) :390-395